{"result": "(\"entity\"<|>HYPONATREMIA<|>EVENT<|>Hyponatremia is a condition characterized by low sodium levels in the blood, which can occur in patients receiving nutritional support and requires careful management.<|>6)\n##\n(\"entity\"<|>HYPERNATREMIA<|>EVENT<|>Hypernatremia is a condition characterized by high sodium levels in the blood, often necessitating adjustments in nutritional support for affected patients.<|>6)\n##\n(\"entity\"<|>HIPOPOTASEMIA<|>EVENT<|>Hypokalemia refers to low potassium levels in the blood, which can result from various factors including nutritional deficiencies and requires monitoring in patients.<|>6)\n##\n(\"entity\"<|>HIPERPOTASEMIA<|>EVENT<|>Hyperkalemia is a condition marked by elevated potassium levels in the blood, often requiring careful management in patients receiving nutritional support.<|>6)\n##\n(\"entity\"<|>HIPOFOSFOREMIA<|>EVENT<|>Hypophosphatemia is a condition characterized by low phosphate levels in the blood, which can occur in critically ill patients and requires monitoring.<|>6)\n##\n(\"entity\"<|>HIPERFOSFOREMIA<|>EVENT<|>Hyperphosphatemia refers to high phosphate levels in the blood, often seen in patients with renal insufficiency and requiring careful management.<|>6)\n##\n(\"entity\"<|>HIPOMAGNESEMIA<|>EVENT<|>Hypomagnesemia is a condition characterized by low magnesium levels in the blood, which can occur due to various factors including nutritional deficiencies.<|>6)\n##\n(\"relationship\"<|>HYPONATREMIA<|>NUTRITIONAL SUPPORT<|>Hyponatremia management is crucial in patients receiving nutritional support to ensure proper sodium levels are maintained.<|>7)\n##\n(\"relationship\"<|>HYPERNATREMIA<|>NUTRITIONAL SUPPORT<|>Hypernatremia management is essential in patients receiving nutritional support to prevent complications related to high sodium levels.<|>7)\n##\n(\"relationship\"<|>HIPOPOTASEMIA<|>NUTRITIONAL SUPPORT<|>Hypokalemia must be monitored and managed in patients receiving nutritional support to maintain appropriate potassium levels.<|>7)\n##\n(\"relationship\"<|>HIPERPOTASEMIA<|>NUTRITIONAL SUPPORT<|>Hyperkalemia requires careful management in patients receiving nutritional support to avoid serious health issues.<|>7)\n##\n(\"relationship\"<|>HIPOFOSFOREMIA<|>NUTRITIONAL SUPPORT<|>Hypophosphatemia is a condition that needs to be addressed in patients on nutritional support to prevent complications.<|>7)\n##\n(\"relationship\"<|>HIPERFOSFOREMIA<|>NUTRITIONAL SUPPORT<|>Hyperphosphatemia management is important in patients receiving nutritional support, especially those with renal issues.<|>7)\n##\n(\"relationship\"<|>HIPOMAGNESEMIA<|>NUTRITIONAL SUPPORT<|>Hypomagnesemia must be monitored in patients receiving nutritional support to ensure adequate magnesium levels.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: u-\n\nsión. Si las concentraciones plasmáticas exceden di- chos valores, se debe considerar la reducción en la can- tidad de lípidos administrados, e incluso modificar el tipo de emulsión lipídico hacia aquellas con más rápido aclaramiento (TCM).\n\n• Manejo de la hipertrigliceridemia38:\n  - Determinación de triglicéridos al inicio y tras 24 horas del inicio de la NP.\n  - Disminuir el aporte de lípidos (no superar 1 g/kg/ día) e incluso suspenderla si persistieran los tri- glicéridos elevados.\n  - Evitar emulsiones lipídicas con aporte exclusivo de TCL.\n\n## 7.2. Alteraciones de electrolitos y minerales\n\nSu déficit se debe a un aporte escaso en la NPT, en relación con los requerimientos del paciente de cada mo- mento. Cuando se pauta una NP se deben cuantificar, no solo los requerimientos de electrolitos, sino también las pérdidas de los mismos (tabla 2) o el aumento de reque- rimientos (síndrome de realimentación).\n\nPara su adecuada administración, deben ser con- trolados sus niveles a diario y ajustarlos en función de los requerimientos65.\n\n• Hiponatremia: Su etiología dependerá del volu- men total infundido, de la cantidad total de sodio aportado y de la enfermedad de base del pacien- te. Es fundamental una exhaustiva exploración fí- sica y un adecuado balance hídrico, para poder establecer un correcto diagnóstico etiológico y un adecuado manejo. Véase el tema 50.\n• Hipernatremia: Como en la hiponatremia, un co- rrecto balance hídrico y una revisión del aporte total de sodio son determinantes para su manejo, Véase el tema 50.\n• Hipopotasemia: Secundaria a pérdidas intesti- nales, urinarias o a un aumento de los requeri- mientos.\n• Hiperpotasemia: Imprescindible descartar afecta- ción renal (disminución de excreción), acidosis metabólica (salida del potasio intracelular) y trata- miento con fármacos ahorradores de potasio.\n• Hipofosforemia: Aumento de requerimientos en pacientes críticos, grandes quemados con función renal conservada.\n• Hiperfosforemia: Excesivo aporte o pacientes con insuficiencia renal\n• Hipomagnesemia: Por pérdidas renales e intesti- nales, fundamentalmente. Su déficit contribuye a la aparición de hipocalcemia.\n\nComo se ha comentado previamente, la administra- ción de calcio y fósforo en la NP debe realizarse con precaución (véase el apartado 5.3), para evitar precipi- tados de fosfato cálcico en la NP, que pueden provocar\n---\n772        BLOQUE: SOPORTE NUTRICIONAL AVANZADO\n\nefectos adversos severos, entre los que se incluyen ca-\nsos mortales de embolia microvascular pulmonar por\nprecipitados de calcio y fósforo66.\n\n7.3. Alteraciones del equilibrio ácido-base25\n\nSe encuentran con frecuencia en pacientes que re-\nciben soporte nutricional, pero en la mayoría de los\ncasos las anomalías no son debidas al régimen de nu-\ntrición aplicado, sino a la enfermedad subyacente,\naunque debemos tener en cuenta que:\n\n• Las soluciones de aminoácidos disponibles para\n  uso intravenoso contienen grandes cantidades\n  de acetato, que tiende a ser alcalinizante.\n• Cuando los requerimientos de sodio o potasio\n  son muy elevados, no se deben utilizar de for-\n  ma exclusiva sales de cloro, sino administrarlo\n  en parte como sales de acetato, para no inducir\n  acidosis metabólica.\n• Se puede ajustar a la situación del paciente,\n  aportando sales de acetato (en acidosis) o de cloro\n  (en alcalosis).\n\n7.4. Déficits nutricionales específicos\n\nPara evitar el déficit de algunos oligoelementos, en\n2012 la ASPEN publicó una modificación de las formu-\nlaciones comerciales de oligoelementos. Los déficits o\nla toxicidad de los oligoelementos se detectan habi-\ntualmente en regímenes de NP prolongadas. En la\ntabla 6, se resume el manejo de los oligoelementos en\nsituaciones clínicas especiales48.\n\nCon las soluciones de multivitamínicos de NP, se cu-\nbren los requerimientos diarios de vitaminas liposolu-\n\nbles e hidrosolubles, aunque se ha observado que el\naporte de vitamina D (200 UI), puede ser insuficiente\nen los pacientes con regímenes de NP prolongados48, 67.\n\n7.5. Complicaciones hepatobiliares (CHB)\n\nLa esteatosis hepática es común 1-\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ASPEN<|>ORGANIZATION<|>ASPEN is an organization that published modifications to commercial formulations of trace elements in 2012 to avoid deficiencies in parenteral nutrition.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPORT<|>EVENT<|>Nutritional support refers to the medical practice of providing nutrition to patients who cannot obtain it by mouth, often through intravenous means.)\n##\n(\"entity\"<|>PATIENT<|>PERSON<|>A patient is an individual receiving medical treatment, particularly in the context of nutritional support and management of their nutritional needs.)\n##\n(\"entity\"<|>HYPERTIGLYCERIDEMIA<|>EVENT<|>Hypertriglyceridemia is a condition characterized by elevated levels of triglycerides in the blood, which can be managed through nutritional interventions.)\n##\n(\"entity\"<|>ELECTROLYTE IMBALANCE<|>EVENT<|>Electrolyte imbalance refers to abnormal levels of electrolytes in the body, which can occur in patients receiving nutritional support.)\n##\n(\"entity\"<|>VITAMINS<|>EVENT<|>Vitamins are essential nutrients that are often included in parenteral nutrition to meet daily requirements for patients.)\n##\n(\"entity\"<|>TRACE ELEMENTS<|>EVENT<|>Trace elements are essential minerals required in small amounts for various bodily functions, often monitored in patients on prolonged parenteral nutrition.)\n##\n(\"relationship\"<|>ASPEN<|>NUTRITIONAL SUPPORT<|>ASPEN published guidelines to improve the management of nutritional support in patients, particularly regarding trace elements and vitamins.<|>7)\n##\n(\"relationship\"<|>PATIENT<|>NUTRITIONAL SUPPORT<|>Patients receive nutritional support when they are unable to meet their nutritional needs through oral intake.<|>8)\n##\n(\"relationship\"<|>HYPERTIGLYCERIDEMIA<|>NUTRITIONAL SUPPORT<|>Management of hypertriglyceridemia often involves adjustments in nutritional support to lower triglyceride levels.<|>6)\n##\n(\"relationship\"<|>ELECTROLYTE IMBALANCE<|>NUTRITIONAL SUPPORT<|>Electrolyte imbalances are frequently monitored and managed in patients receiving nutritional support.<|>7)\n##\n(\"relationship\"<|>VITAMINS<|>NUTRITIONAL SUPPORT<|>Vitamins are included in nutritional support formulations to ensure patients receive adequate nutrition.<|>8)\n##\n(\"relationship\"<|>TRACE ELEMENTS<|>NUTRITIONAL SUPPORT<|>Trace elements are critical components of nutritional support that need to be monitored to prevent deficiencies.<|>7)\n<|COMPLETE|>"}]}